EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 0. It has been cited 34 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institue
Grant: 5T32BM008361
National Cancer Institute
Grant: T32 CA229102
National Cancer Institute
Grant: T32 CA183926
National Cancer Institute
Grant: T32 CA091078
University of Alabama at Birmingham, Flow Cytometry Core
Grant: P30 AR048311 and P30 AI27667
NIAMS NIH HHS
Grant: P30 AR048311
National Institutes of Health
Grant: 5T32CA229102-08
Surgical Oncology Research Training Program
National Institutes of Health
Grant: 5T32CA183926-02
Research Training Program in Basic and Translational Oncology
National Institutes of Health
Grant: 5P30AR048311-08
Analytic and Preparative Cytometry Facility
National Institutes of Health
Grant: 5T32CA091078-08
Research Training Program in Surgical Oncology
Sid Strong Foundation
Elaine Roberts Foundation
Open Hearts Overflowing Hands
Lombardi Cancer Research Fund/Starr Children’s Fund
FWCI
2.28
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals